Concepedia

Mary C. Hornick

MC

Statistics

Publications

4

Citations

293

H-Index

4

Active since

2011

Affiliations

Washington University in St. Louis(Current)

Mallinckrodt (United States)

Imaging Center

Mary C. Hornick is an author at Washington University in St. Louis specializing in medicine, pharmacotherapy, and medicinal chemistry.

Top concepts

Publications per year

2011–2014

4

Publications

4

The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects

Michelle A. Hurchla, Antonio García-Gómez, Mary C. Hornick et al. · Leukemia · 2012 · 143 citations · Full text

, , +7

Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment

Emanuela Heller, Michelle A. Hurchla, Jingyu Xiang et al. · Cancer Research · 2011 · 77 citations · Full text

, , +17

Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV‐134

Yassar M. Hashim, Dirk Spitzer, Suwanna Vangveravong et al. · Molecular Oncology · 2014 · 42 citations · Full text

Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer

Gunjal Garg, Suwanna Vangveravong, Chenbo Zeng et al. · Molecular Cancer · 2014 · 31 citations · Full text

1–4 of 4